Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Kristen Kay to Cell Line, Tumor

This is a "connection" page, showing publications Kristen Kay has written about Cell Line, Tumor.

 
Connection Strength
 
 
 
0.189
 
  1. Kay KE, Lee J, Hong ES, Beilis J, Dayal S, Wesley ER, Mitchell S, Wang SZ, Silver DJ, Volovetz J, Johnson S, McGraw M, Grabowski MM, Lu T, Freytag L, Narayana V, Freytag S, Best SA, Whittle JR, Wang Z, Reizes O, Yu JS, Hazen SL, Brown JM, Bayik D, Lathia JD. Tumor cell-derived spermidine promotes a protumorigenic immune microenvironment in glioblastoma via CD8+ T cell inhibition. J Clin Invest. 2024 Nov 19; 135(2).
    View in: PubMed
    Score: 0.123
  2. Wang SZ, Timken JP, Hong ES, Kaur S, Newby E, Kay KE, Mulkearns-Hubert EE, Silver DJ, Lee J, Rubin JB, Connor JR, Deleyrolle LP, Tiek D, Dhawan A, Lathia JD. Lipocalin 2 orchestrates resistance to ferroptosis via AXL. Cell Rep. 2026 Mar 24; 45(3):116965.
    View in: PubMed
    Score: 0.034
  3. Mulkearns-Hubert EE, Hajdari N, Hong ES, Jacobs AP, Gaboriau A, Giltner S, Tannish G, Kay KE, Wang SZ, LaViolette PS, Silver DJ, Hubert CG, Dhawan A, Lathia JD. Connexin 43 drives glioblastoma cancer stem cell phenotypes through a WNK lysine-deficient protein kinase 1-c-MYC signaling axis. Cell Rep. 2025 Sep 23; 44(9):116303.
    View in: PubMed
    Score: 0.033
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)